
Amy B. Vanatta
Examiner (ID: 14877, Phone: (571)272-4995 , Office: P/3765 )
| Most Active Art Unit | 3732 |
| Art Unit(s) | 2741, 3408, 3741, 3732, 2407, 3765 |
| Total Applications | 2829 |
| Issued Applications | 2065 |
| Pending Applications | 154 |
| Abandoned Applications | 634 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 4186247
[patent_doc_number] => 06160012
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-12-12
[patent_title] => 'Leukotriene B.sub.4 derivatives, in particular oximo-LTB.sub.4 - antagonists'
[patent_app_type] => 1
[patent_app_number] => 9/423336
[patent_app_country] => US
[patent_app_date] => 2000-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16435
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 444
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/160/06160012.pdf
[firstpage_image] =>[orig_patent_app_number] => 423336
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/423336 | Leukotriene B.sub.4 derivatives, in particular oximo-LTB.sub.4 - antagonists | Mar 26, 2000 | Issued |
Array
(
[id] => 1414968
[patent_doc_number] => 06525080
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-02-25
[patent_title] => 'Thiazoline acid derivatives'
[patent_app_type] => B1
[patent_app_number] => 09/531755
[patent_app_country] => US
[patent_app_date] => 2000-03-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 4883
[patent_no_of_claims] => 60
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/525/06525080.pdf
[firstpage_image] =>[orig_patent_app_number] => 09531755
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/531755 | Thiazoline acid derivatives | Mar 19, 2000 | Issued |
Array
(
[id] => 1416893
[patent_doc_number] => 06521652
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-02-18
[patent_title] => 'Thiazoline acid derivatives'
[patent_app_type] => B1
[patent_app_number] => 09/531754
[patent_app_country] => US
[patent_app_date] => 2000-03-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 4907
[patent_no_of_claims] => 52
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 110
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/521/06521652.pdf
[firstpage_image] =>[orig_patent_app_number] => 09531754
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/531754 | Thiazoline acid derivatives | Mar 19, 2000 | Issued |
Array
(
[id] => 1381182
[patent_doc_number] => 06559315
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-05-06
[patent_title] => 'Thiazoline acid derivatives'
[patent_app_type] => B1
[patent_app_number] => 09/531753
[patent_app_country] => US
[patent_app_date] => 2000-03-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 4904
[patent_no_of_claims] => 56
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 79
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/559/06559315.pdf
[firstpage_image] =>[orig_patent_app_number] => 09531753
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/531753 | Thiazoline acid derivatives | Mar 19, 2000 | Issued |
Array
(
[id] => 4421418
[patent_doc_number] => 06225288
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-05-01
[patent_title] => 'Gamma-ketoacid dipeptides as inhibitors of caspase-3'
[patent_app_type] => 1
[patent_app_number] => 9/526840
[patent_app_country] => US
[patent_app_date] => 2000-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14163
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 327
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/225/06225288.pdf
[firstpage_image] =>[orig_patent_app_number] => 526840
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/526840 | Gamma-ketoacid dipeptides as inhibitors of caspase-3 | Mar 15, 2000 | Issued |
| 60/304184 | Organic compounds | Mar 13, 2000 | Pending |
Array
(
[id] => 4185930
[patent_doc_number] => 06159994
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-12-12
[patent_title] => 'Histamine H.sub.3 receptor ligands'
[patent_app_type] => 1
[patent_app_number] => 9/462910
[patent_app_country] => US
[patent_app_date] => 2000-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 7069
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 381
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/159/06159994.pdf
[firstpage_image] =>[orig_patent_app_number] => 462910
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/462910 | Histamine H.sub.3 receptor ligands | Mar 12, 2000 | Issued |
Array
(
[id] => 1551141
[patent_doc_number] => 06399639
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-06-04
[patent_title] => 'Apoptosis inhibitor'
[patent_app_type] => B1
[patent_app_number] => 09/519274
[patent_app_country] => US
[patent_app_date] => 2000-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6600
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/399/06399639.pdf
[firstpage_image] =>[orig_patent_app_number] => 09519274
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/519274 | Apoptosis inhibitor | Mar 6, 2000 | Issued |
Array
(
[id] => 1524092
[patent_doc_number] => 06353011
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-03-05
[patent_title] => '1,2-dithiolane derivatives'
[patent_app_type] => B1
[patent_app_number] => 09/520208
[patent_app_country] => US
[patent_app_date] => 2000-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 19435
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 267
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/353/06353011.pdf
[firstpage_image] =>[orig_patent_app_number] => 09520208
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/520208 | 1,2-dithiolane derivatives | Mar 6, 2000 | Issued |
Array
(
[id] => 1451473
[patent_doc_number] => 06455709
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-09-24
[patent_title] => 'E-isomeric fullerene derivatives'
[patent_app_type] => B1
[patent_app_number] => 09/521025
[patent_app_country] => US
[patent_app_date] => 2000-03-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14565
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 1819
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/455/06455709.pdf
[firstpage_image] =>[orig_patent_app_number] => 09521025
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/521025 | E-isomeric fullerene derivatives | Mar 5, 2000 | Issued |
Array
(
[id] => 1397387
[patent_doc_number] => 06541497
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-04-01
[patent_title] => 'Hypoglycemic and hypolipidemic compounds'
[patent_app_type] => B1
[patent_app_number] => 09/518607
[patent_app_country] => US
[patent_app_date] => 2000-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19922
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 89
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/541/06541497.pdf
[firstpage_image] =>[orig_patent_app_number] => 09518607
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/518607 | Hypoglycemic and hypolipidemic compounds | Mar 2, 2000 | Issued |
| 09/486995 | PROTEASE INHIBITORS | Mar 2, 2000 | Abandoned |
Array
(
[id] => 1524189
[patent_doc_number] => 06353027
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-03-05
[patent_title] => 'Hypoglycemic and hypolipidemic compounds'
[patent_app_type] => B1
[patent_app_number] => 09/518537
[patent_app_country] => US
[patent_app_date] => 2000-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19743
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 189
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/353/06353027.pdf
[firstpage_image] =>[orig_patent_app_number] => 09518537
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/518537 | Hypoglycemic and hypolipidemic compounds | Mar 2, 2000 | Issued |
Array
(
[id] => 1485734
[patent_doc_number] => 06365611
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-04-02
[patent_title] => 'Pentaerythrite derivatives, the production and use thereof and intermediate products for the synthesis of the same'
[patent_app_type] => B1
[patent_app_number] => 09/445782
[patent_app_country] => US
[patent_app_date] => 2000-02-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6917
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/365/06365611.pdf
[firstpage_image] =>[orig_patent_app_number] => 09445782
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/445782 | Pentaerythrite derivatives, the production and use thereof and intermediate products for the synthesis of the same | Feb 28, 2000 | Issued |
Array
(
[id] => 1520938
[patent_doc_number] => 06413945
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-07-02
[patent_title] => 'Gastro-specific prodrugs'
[patent_app_type] => B1
[patent_app_number] => 09/514819
[patent_app_country] => US
[patent_app_date] => 2000-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8933
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 96
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/413/06413945.pdf
[firstpage_image] =>[orig_patent_app_number] => 09514819
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/514819 | Gastro-specific prodrugs | Feb 27, 2000 | Issued |
Array
(
[id] => 1418157
[patent_doc_number] => 06518292
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-02-11
[patent_title] => 'Heterocyclic aromatic compounds usefuls as growth hormone secretagogues'
[patent_app_type] => B1
[patent_app_number] => 09/506749
[patent_app_country] => US
[patent_app_date] => 2000-02-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21577
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 1203
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/518/06518292.pdf
[firstpage_image] =>[orig_patent_app_number] => 09506749
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/506749 | Heterocyclic aromatic compounds usefuls as growth hormone secretagogues | Feb 17, 2000 | Issued |
Array
(
[id] => 1595486
[patent_doc_number] => 06384075
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-05-07
[patent_title] => 'Bicyclic amino derivatives and PGD2, antagonist containing them'
[patent_app_type] => B1
[patent_app_number] => 09/506608
[patent_app_country] => US
[patent_app_date] => 2000-02-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 48603
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 316
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/384/06384075.pdf
[firstpage_image] =>[orig_patent_app_number] => 09506608
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/506608 | Bicyclic amino derivatives and PGD2, antagonist containing them | Feb 17, 2000 | Issued |
Array
(
[id] => 4352799
[patent_doc_number] => 06214998
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-04-10
[patent_title] => 'Process for preparing 2-chloro-5-chloromethylthiazole'
[patent_app_type] => 1
[patent_app_number] => 9/507341
[patent_app_country] => US
[patent_app_date] => 2000-02-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1483
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/214/06214998.pdf
[firstpage_image] =>[orig_patent_app_number] => 507341
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/507341 | Process for preparing 2-chloro-5-chloromethylthiazole | Feb 17, 2000 | Issued |
Array
(
[id] => 1570631
[patent_doc_number] => 06498190
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-12-24
[patent_title] => 'Bicyclic amino derivatives and PGD2 antagonist containing the same'
[patent_app_type] => B1
[patent_app_number] => 09/506606
[patent_app_country] => US
[patent_app_date] => 2000-02-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 48653
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 392
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/498/06498190.pdf
[firstpage_image] =>[orig_patent_app_number] => 09506606
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/506606 | Bicyclic amino derivatives and PGD2 antagonist containing the same | Feb 17, 2000 | Issued |
Array
(
[id] => 4384116
[patent_doc_number] => 06262094
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-07-17
[patent_title] => 'C-21 modified epothilones'
[patent_app_type] => 1
[patent_app_number] => 9/506481
[patent_app_country] => US
[patent_app_date] => 2000-02-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17733
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 124
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/262/06262094.pdf
[firstpage_image] =>[orig_patent_app_number] => 506481
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/506481 | C-21 modified epothilones | Feb 16, 2000 | Issued |